Bill Baruch on SpaceX: Buying the Unlock and Looking Past Starlink

Bill Baruch says he has been buying SpaceX personally over the past week, and his approach is to put it away and let the story develop over the next six months. While most of the market leans on Starlink and the data centers in space narrative, Bill thinks the compute side is where the real […]

Bill Baruch’s Three Pillars: Why He Sees the S&P at 8,000

Bill Baruch laid out the three factors he flagged to clients two weeks ago, back when the SMH was roughly 25 percent off its highs and he thought the selloff was overdone. First, the Fed is misunderstood. He believes hawkish expectations are offsides, pointing to Powell’s comment that oil price shocks are not something monetary […]

Bill Baruch Likes AbbVie’s Breakout as Humira Losses Get Replaced

Bill Baruch is looking at AbbVie as a healthcare name outside of the tech trade. He pointed to 7 percent earnings growth and an expected 24 percent revenue growth ahead, with Skyrizi and Rinvoq now making up for the revenue AbbVie lost as Humira came off patent. The stock is only up about 7 percent […]

Bill Baruch’s Final Trade: Nebius Group Set to Snap Back

Bill Baruch joined CNBC’s Halftime Report for his final trade, picking Nebius Group. He calls it an AI infrastructure name with an ultra growth story that has sold off nearly half from its recent high into major support. He thinks that it snaps back quickly, though he flagged it as one of the more volatile […]

Micron’s Pop Signals Capitulation on CapEx Fears, Says Bill Baruch

Bill Baruch flagged Micron as a signal he’s been watching for a couple of weeks. After its last earnings report, memory stocks including Micron ran the following day, and he reads that move as capitulation on the market’s fear around AI CapEx spending. It’s part of a broader thesis he holds on the Mag Seven […]

This Selloff Looks Like August — Bill Baruch Stays Bullish but Wants Proof

Bill Baruch thinks the selloff got exacerbated — exploding put volume, leveraged ETF selling, and profit-taking after tech charts ran straight up to the right. He’s comparing it to August 2024’s sharp drop that became the low before the summer rally kicked in. But he’s not fully convinced yet: he needs to see healthcare and […]